ENSC

Ensysce Biosciences, Inc.

Latest Form 4:Purchase$246KbyGOWER BOB G (Director) · filed Aug 18, 2026

Ensysce Biosciences, Inc. (ENSC) has 1 SEC Form 4 filing (2 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Aug 18, 2026.

Insiders have net bought $444K over the trailing 6 months.

  • Industry:Biotechnology
  • CEO:D. Lynn Kirkpatrick
  • Employees:9
  • HQ:La Jolla, CA, US
  • IPO:2018-03-14

Insider Buying

$444K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Unique Insiders

1

in the rolling window

Market Cap

$7.8M

latest known value

Source
GOWER BOB GFirst filing
Purchase$246KAug 18SEC ↗
GOWER BOB GFirst filing
Purchase$198KAug 18SEC ↗

Related companies

Ensysce Biosciences, Inc. is in the Healthcare sector.